Interestingly, we found that ACC1 and FAS were increased by STZ treatment, while DGAT2 was upregulated in HFD-treated mice (Figure 2B), indicating that hyperglycemia and hyperlipidemia might promote lipogenesis by activating distinct lipogenic genes, respectively. This evidence concerns the gene FAS and hyperlipidemia.